<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The goal of the present study was to evaluate the activation patterns of p38 <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase (MAPK) in <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPDs</z:e>) and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (MDSs) </plain></SENT>
<SENT sid="1" pm="."><plain>Phosphorylated (activated) p38 MAPK was analyzed immunohistochemically in formalin-fixed decalcified bone marrow core biopsy specimens from 32 MPD, 33 MDS, and 11 control cases </plain></SENT>
<SENT sid="2" pm="."><plain>Moderate p38 activation was commonly seen in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, whereas weak p38 activation was seen in <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e> cases and <z:hpo ids='HP_0000001'>all</z:hpo> control cases but 1 in the erythroid lineage </plain></SENT>
<SENT sid="3" pm="."><plain>In myeloid and megakaryocytic lineages, strong p38 activation was more commonly observed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> compared with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e> (myeloid, 22/33 vs 2/32; P &lt; .0001; megakaryocytic, 18/23 vs 5/32; P &lt; .0001) and control (myeloid, 22/33 vs 2/11; P = .012; megakaryocytic, 18/23 vs 3/9; P = .035) cases </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, weak p38 activation was observed in myeloid and megakaryocytic lineages in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e> compared with control (myeloid, 15/32 vs 1/11; P = .033; megakaryocytic, 16/32 vs 0/9; P = .007) cases </plain></SENT>
<SENT sid="5" pm="."><plain>Increased p38 MAPK activation may have a role in inhibiting hematopoiesis leading to cytopenias in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, and relatively decreased p38 activation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e> might promote hematopoiesis, resulting in cytosis </plain></SENT>
</text></document>